Trial Profile
Comparison of 2 contrast agents in preventing acute renal failure after angiography
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Iodixanol (Primary) ; Iopamidol
- Indications Acute kidney injury
- Focus Therapeutic Use
- 23 Mar 2017 New trial record